SCHEMBL3872235

SCHEMBL3872235

O=C(Cl)CCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10359881 0.90
SCHEMBL10455968 0.88 TSHR (0.59)
SCHEMBL21295305 0.88 TSHR (0.59)
1,6-Hexanediol SCHEMBL6558431 0.88 TSHR (0.59)
SCHEMBL202630 0.88
Ethylene Glycol SCHEMBL6557377 0.87 TSHR (0.57)
1,4-Butanediol SCHEMBL28048097 0.87 ALDH1A1 (0.48)
Ethylene Glycol SCHEMBL6557487 0.84 TSHR (0.62)
SCHEMBL180666 0.82
SCHEMBL132364 0.82 TSHR (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103145737-B Preparation method for cefbuperazone LIVZON SYNTPHARM CO LTD ZHUHAI FTZ 2015-04-29 CN claimed
CN-103145737-A Preparation method for cefbuperazone LIVZON SYNTPHARM CO LTD ZHUHAI FTZ 2013-06-12 CN claimed
CN-115353475-B Preparation method of levetiracetam 浙江京新药业股份有限公司 2024-04-26 CN disclosed
CN-115353475-A Preparation method of levetiracetam 浙江京新药业股份有限公司 2022-11-18 CN disclosed
US-20160016986-A1 STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENT ACHILLION PHARMACEUTICALS, INC. 2016-01-21 US disclosed
CN-103145737-B Preparation method for cefbuperazone LIVZON SYNTPHARM CO LTD ZHUHAI FTZ 2015-04-29 CN disclosed
CN-103145737-A Preparation method for cefbuperazone LIVZON SYNTPHARM CO LTD ZHUHAI FTZ 2013-06-12 CN disclosed
CN-101066294-B Chinese medicine prepn for invigorating kidney to reduce urination and its prepn DARENTANG MEDICINE FACTORY TIANJIN ZHONGXIN PHARMACEUTICAL INDUSTRY GROUP CORP 2011-11-02 CN disclosed
US-7550475-B2 Condensed polycyclic compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-06-23 US disclosed
US-7550476-B2 Condensed polycyclic compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-06-23 US disclosed
US-7550464-B2 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis MITSUBISHI TANBE PHARMA CORPORATION (JP) 2009-06-23 US disclosed
CN-101066294-A Chinese medicine prepn for invigorating kidney to reduce urination and its prepn DARENTANG MEDICINE FACTORY TIA (CN) 2007-11-07 CN disclosed
US-20070010521-A1 Condensed polycyclic compounds TANABE SEIYAKU CO., LTD. 2007-01-11 US disclosed
US-20070004739-A1 Condensed polycyclic compounds TANABE SEIYAKU CO., LTD. 2007-01-04 US disclosed
US-20070004740-A1 Condensed polycyclic compounds TANABE SEIYAKU CO., LTD. 2007-01-04 US disclosed
US-7153859-B2 Condensed polycyclic compounds TANABE SEIYAKU CO., LTD. (JP) 2006-12-26 US disclosed
US-20040204418-A1 Fused-polycyclic compounds TANABE SEIYAKU CO., LTD. (JP) 2004-10-14 US disclosed
EP-1424326-A1 FUSED-POLYCYCLIC COMPOUNDS TANABE SEIYAKU CO., LTD. (JP) 2004-06-02 EP disclosed
US-4054570-A NEUROLEPTIC AGENTS CIBA-GEIGY CORPORATION (US) 1977-10-18 US disclosed
US-3992546-A 4-Piperidinobutyrophenones as neuroleptics CIBA-GEIGY CORPORATION (US) 1976-11-16 US disclosed